Frequency of Infusion Reactions in Novel Versus Standard Protocol in Multiple Sclerosis (DBCOND0134510)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04633967	Observational Study of a Novel Peri Infusion Regimen on the Infusion Associated Reactions With Alemtuzumab Infusion in Patients With Multiple Sclerosis in a Canadian Clinical Setting.	Alemtuzumab	Not Available	Not Available	completed